Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
- PMID: 32473642
- PMCID: PMC7261036
- DOI: 10.1186/s12941-020-00368-w
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
Keywords: 2019-nCoV; COVID-19; Coronavirus; Ivermectin; SARS-CoV-2; Therapeutics.
Conflict of interest statement
None.
Figures
Comment on
-
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3. Antiviral Res. 2020. PMID: 32251768 Free PMC article.
References
-
- Rang HP, Dale MM, Ritter JM, Flower RJ, editors. Rang and Dale’s Pharmacology. 6. China: Churchill Livingstone; 2007. pp. 715–716.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
